Literature DB >> 31918393

I. inflexus (Thunb.) Kudo extract improves atopic dermatitis and depressive-like behavior in DfE-induced atopic dermatitis-like disease.

Sun Haeng Park1, Seol Jang1, Jeong Eun An1, Byung Kil Choo2, Ho Kyoung Kim3.   

Abstract

BACKGROUND: Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease, which is caused by several genetic, immunological, and environmental factors. In addition to skin manifestations, AD is associated with an increased risk of depression and suicidal ideation. Furthermore, this association is underappreciated and therefore insufficiently studied. HYPOTHESIS/
PURPOSE: We investigated the association between AD and depression and the effect of I. inflexus (Thunb.) Kudo extract (IIE) treatment in a Dermatophagoides farinae extract (DfE)-induced mouse model of AD. STUDY
DESIGN: We evaluated the effects of IIE on depressive behavior in AD mice using four experimental groups: normal (untreated), AD mice (untreated Dfe-induced), IIE-treated (Dfe-induced AD mice), and positive control (tacrolimus-treated Dfe-induced AD mice).
METHODS: An AD model was established by the application of 4% sodium dodecyl sulfate to the shaved dorsal neck skin and ears of NC/Nga mice 1 h before application of 100 mg DfE twice per week for 3 weeks. After the first week of DfE application, mice were treated with IIE every day for the remaining 2 weeks. We performed behavioral testing, histology, ELISA, and western blotting to assess depressive-like behavior and neuroinflammatory responses and to measure IgE, histamine, corticosterone, and serotonin levels.
RESULTS: Compared with normal mice, AD mice showed more scratching behavior, increased ear swelling, and higher serum levels of IgE and histamine. AD mice also exhibited evidence of depressive-like behavior in the open-field and sucrose preference tests as well as altered serum corticosterone and brain serotonin concentrations. Histopathological analyses revealed increased infiltration of inflammatory cells and mast cells into the skin and ear tissue and elevated microglia activation and neuroinflammatory response in the brains of AD mice. Topical application of IIE reversed the effects of AD on scratching behavior, ear swelling, open-field locomotion, sucrose preference, and levels of IgE, histamine, corticosterone, serotonin, and inflammatory markers. Moreover, IIE treatment reduced inflammatory cytokine responses in keratinocyte cells.
CONCLUSION: IIE is a candidate anti-AD therapy due to its ability to exert neuroprotective and antidepressant effects.
Copyright © 2019. Published by Elsevier GmbH.

Entities:  

Keywords:  Atopic dermatitis; Depression; I. inflexus (Thunb.) Kudo extract; Inflammation; NC/Nga mice

Mesh:

Substances:

Year:  2019        PMID: 31918393     DOI: 10.1016/j.phymed.2019.153137

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  4 in total

1.  Spatholobus suberectus Dunn Water Extract Ameliorates Atopic Dermatitis-Like Symptoms by Suppressing Proinflammatory Chemokine Production In Vivo and In Vitro.

Authors:  Hyun-Kyung Song; Sun Haeng Park; Hye Jin Kim; Seol Jang; Taesoo Kim
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

2.  Management of Atopic Dermatitis Via Oral and Topical Administration of Herbs in Murine Model: A Systematic Review.

Authors:  Vivi Nur Khalieda Mohd Kasim; Siti Mahirah Noble; Kong Yen Liew; Ji Wei Tan; Daud Ahmad Israf; Chau Ling Tham
Journal:  Front Pharmacol       Date:  2022-05-24       Impact factor: 5.988

3.  A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa.

Authors:  Michele Fabrazzo; Salvatore Cipolla; Simona Signoriello; Alessio Camerlengo; Giulia Calabrese; Giulia Maria Giordano; Giuseppe Argenziano; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2021-11-25       Impact factor: 5.361

4.  Chronic allergic lung inflammation negatively influences neurobehavioral outcomes in mice.

Authors:  Akihiro Kanaya; Mu Yang; Charles Emala; Maya Mikami
Journal:  J Neuroinflammation       Date:  2022-08-31       Impact factor: 9.587

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.